Technology Assisted Treatment of Trichotillomania: Open Trial
NCT07224126
Summary
This open-label feasibility trial evaluates the use of the Keen2 awareness bracelet for adults with trichotillomania (hair-pulling disorder). Participants will use the bracelet for eight weeks. During the first four weeks, they will wear the device and log contextual information (such as emotions, location, and activity) after each detected hair-pulling episode. Based on these data, participants will then receive tailored predictive alerts designed to support use of stimulus control, competing responses, and coping strategies. The study will assess usability, adherence, and changes in self-reported hair-pulling severity and awareness.
Eligibility
Inclusion Criteria: * 18 years of age (criterion 1a) with a diagnosis of TTM (criterion 1b) * Must reportEnglish as their primary language (criterion 2) * Report no current pharmacological or psychosocial intervention targeting TTM symptoms OR a6-week course of either intervention modality without change in frequency,intensity, or dosage (criterion 3) * Reliable and consistent access to the internet and/or mobile device permitting the participant to meet withsomeone virtually for 90 min. * Must report owning/access to a mobilephone running on Apple's operating system (iOS) * Identifies a support person that is able to be contacted is an emergency arises. * Agrees to allow the Kent State research team to share home address, mobile number, andalternate number/email with HabitAware, Inc., for purposes of mailing Keen2device and setting up Keen2 system. Exclusion Criteria: * Current suicidal/homicidal ideation, intent, or plan * a diagnosis of another psychiatric condition that may impeded a participant's ability to fully utilize the app (e.g., psychotic disorder, major depressive disorder)
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07224126